EP2480078A4 - Pyrido[4,3-b]indoles et leurs méthodes d'utilisation - Google Patents
Pyrido[4,3-b]indoles et leurs méthodes d'utilisationInfo
- Publication number
- EP2480078A4 EP2480078A4 EP10819490A EP10819490A EP2480078A4 EP 2480078 A4 EP2480078 A4 EP 2480078A4 EP 10819490 A EP10819490 A EP 10819490A EP 10819490 A EP10819490 A EP 10819490A EP 2480078 A4 EP2480078 A4 EP 2480078A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- indoles
- pyrido
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24525909P | 2009-09-23 | 2009-09-23 | |
US24514009P | 2009-09-23 | 2009-09-23 | |
PCT/US2010/050078 WO2011038161A1 (fr) | 2009-09-23 | 2010-09-23 | Pyrido[4,3-b]indoles et leurs méthodes d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2480078A1 EP2480078A1 (fr) | 2012-08-01 |
EP2480078A4 true EP2480078A4 (fr) | 2013-03-06 |
Family
ID=43796209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10819490A Withdrawn EP2480078A4 (fr) | 2009-09-23 | 2010-09-23 | Pyrido[4,3-b]indoles et leurs méthodes d'utilisation |
Country Status (9)
Country | Link |
---|---|
US (5) | US8859561B2 (fr) |
EP (1) | EP2480078A4 (fr) |
JP (1) | JP5779183B2 (fr) |
CN (1) | CN102711468B (fr) |
AU (1) | AU2010298166B2 (fr) |
BR (1) | BR112012006640A2 (fr) |
CA (1) | CA2775328A1 (fr) |
HK (1) | HK1176811A1 (fr) |
WO (1) | WO2011038161A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
RU2544856C2 (ru) | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
CA2718790A1 (fr) * | 2008-03-24 | 2009-10-01 | Medivation Technologies, Inc. | Composes heterocycliques pontes et leurs procedes d'utilisation |
CL2009000724A1 (es) | 2008-03-24 | 2009-05-29 | Medivation Technologies Inc | Compuestos derivados de 1,2,3,4-tetrahidro-pirido[3,4-b]indol, moduladores del receptor de histamina, serotonina y dopamina; composicion farmaceutica; kit farmaceutico; y uso para tratar un trastorno cognitivo, psicotico, mediado por neurotransmisores y/o neurologico. |
EP2346332A4 (fr) | 2008-10-31 | 2012-08-08 | Medivation Technologies Inc | Pyridoý4,3-b¨indoles contenant des fragments rigides |
AR073924A1 (es) * | 2008-10-31 | 2010-12-09 | Medivation Technologies Inc | Azepino[4, 5-b]indoles, una composicion farmaceutica y kits que los comprenden y su uso en la modulacion de un receptor de histamina. |
EP2424366B1 (fr) | 2009-04-29 | 2016-02-17 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles et leurs méthodes d'utilisation |
CN102480955B (zh) | 2009-04-29 | 2015-08-05 | 梅迪维新技术公司 | 吡啶并[4,3-b]吲哚类和使用方法 |
AU2010298168B2 (en) | 2009-09-23 | 2015-11-19 | Medivation Technologies, Inc. | Pyrido(3,4-b)indoles and methods of use |
JP5779183B2 (ja) | 2009-09-23 | 2015-09-16 | メディベイション テクノロジーズ, インコーポレイテッド | ピリド[4,3−b]インドールおよび使用方法 |
WO2011038164A1 (fr) | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Composés hétérocycliques pontés et leurs méthodes d'utilisation |
US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
WO2011103433A1 (fr) | 2010-02-18 | 2011-08-25 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole et dérivés de pyrido[3,4-b]indole et procédés d'utilisation |
US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
WO2011103430A1 (fr) | 2010-02-19 | 2011-08-25 | Medivation Technologies, Inc. | Dérivés de pyrido[4,3-b]indole et de pyrido[3,4-b]indole et procédés d'utilisation |
WO2012112964A2 (fr) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Dérivés de pyrido[4,3-b]indole et de pyrido[3,4-b]indole et procédés d'utilisation |
WO2012112963A1 (fr) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Composés et procédés pour le traitement de l'hypertension |
IN2013MN01699A (fr) | 2011-02-18 | 2015-06-12 | Medivation Technologies Inc | |
US20140303144A1 (en) | 2011-02-18 | 2014-10-09 | Medivation Technologies, Inc. | Compounds and methods of treating hypertension |
WO2014207241A1 (fr) * | 2013-06-28 | 2014-12-31 | Alzprotect | Nouveaux composés de carboline substitués par na pouvant être utilisés pour le traitement de maladies neurodégénératives |
WO2019090001A1 (fr) * | 2017-11-02 | 2019-05-09 | California Institute Of Technology | Antagonistes de la neurokinine et utilisations associées |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009120720A1 (fr) * | 2008-03-24 | 2009-10-01 | Medivation Technologies,Inc. | Composés hétérocycliques pontés et leurs procédés d'utilisation |
WO2010036998A2 (fr) * | 2008-09-29 | 2010-04-01 | Abbott Laboratories | Dérivés d’indole et d’indoline et procédés d’utilisation de ceux-ci |
WO2011008312A2 (fr) * | 2009-07-14 | 2011-01-20 | Abbott Laboratories | Dérivés indole et indoline et leurs procédés dutilisation |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4360673A (en) | 1980-03-31 | 1982-11-23 | Schering Corporation | 5 Phenyl-1,3-alkano-1,2,3,4,4a,9b-hexahydropyrido [4,3-b]indoles |
US5273977A (en) | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
ES2101824T3 (es) * | 1991-08-15 | 1997-07-16 | Ciba Geigy Ag | N-acil-n-heterociclil-onaftalenil-alquil-aminoacidos como antagonistas de angiotensina ii. |
US5250537A (en) | 1992-03-13 | 1993-10-05 | Scios Nova Inc. | 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives |
RU2106864C1 (ru) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
US6251893B1 (en) * | 1998-06-15 | 2001-06-26 | Nps Allelix Corp. | Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity |
US20070179174A1 (en) | 2003-12-08 | 2007-08-02 | Bachurin Sergei O | Methods and compositions for slowing aging |
RU2283108C2 (ru) | 2003-12-08 | 2006-09-10 | Сергей Олегович Бачурин | ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
JP2009506988A (ja) | 2005-08-19 | 2009-02-19 | エラン ファーマシューティカルズ,インコーポレイテッド | ガンマセクレターゼの架橋n−環状スルホンアミド阻害剤 |
US20070117834A1 (en) | 2005-10-04 | 2007-05-24 | David Hung | Methods and compositions for treating Huntington's disease |
RU2338537C2 (ru) | 2006-01-25 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
JP2010504338A (ja) | 2006-09-20 | 2010-02-12 | メディベイション ニューロロジー, インコーポレイテッド | 筋萎縮性側索硬化症(ALS)の治療のための水素化ピリド[4,3−b]インドール |
EP2066322A2 (fr) | 2006-09-20 | 2009-06-10 | Medivation Neurology, Inc. | Pyrido [4, 3-b] indoles hydrogénés comme par example dimebon pour le traitement du syndrome de dysfonctionnement cognitif |
CA2667553A1 (fr) | 2006-10-27 | 2008-05-02 | Medivation Neurology, Inc. | Procedes et combinaison de therapies pour le traitement de la maladie d'alzheimer |
RU2329044C1 (ru) | 2006-11-16 | 2008-07-20 | Андрей Александрович Иващенко | Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство |
RU2334514C1 (ru) | 2006-12-01 | 2008-09-27 | Институт физиологически активных веществ Российской Академии наук | СРЕДСТВО ДЛЯ УЛУЧШЕНИЯ КОГНИТИВНЫХ ФУНКЦИЙ И ПАМЯТИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО (4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
RU2340342C2 (ru) | 2006-12-07 | 2008-12-10 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И ХРОНИЧЕСКИХ НАРУШЕНИЙ МОЗГОВОГО КРОВООБРАЩЕНИЯ, В ТОМ ЧИСЛЕ ИНСУЛЬТА, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО[4,3-b]ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
RU2338745C1 (ru) | 2007-03-21 | 2008-11-20 | Андрей Александрович Иващенко | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
US8541437B2 (en) | 2007-04-05 | 2013-09-24 | Alla Chem, Llc | Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof |
RU2339637C1 (ru) * | 2007-04-05 | 2008-11-27 | Андрей Александрович Иващенко | Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием |
AU2008257152A1 (en) | 2007-05-25 | 2008-12-04 | Medivation Neurology, Inc. | Methods and compositions for stimulating cells |
RU2338533C1 (ru) | 2007-06-28 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО, ОБЛАДАЮЩЕЕ АНКСИОЛИТИЧЕСКИМ ДЕЙСТВИЕМ, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
US20110269777A1 (en) | 2007-08-01 | 2011-11-03 | Medivation Neurology, Inc. | Methods and compositions for treating schizophrenia using antipsychotic combination therapy |
WO2009039420A1 (fr) | 2007-09-21 | 2009-03-26 | Medivation Neurology, Inc. | Procédés et compositions pour traiter des maladies oculaires véhiculées par une mort neuronale |
RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
WO2009082268A2 (fr) | 2007-12-21 | 2009-07-02 | Alla Chem, Llc | Ligands dalpha-adrénorécepteurs, de récepteurs de dopamine, de l'histamine, d'imidazoline et de sérotonine ainsi que leurs procédés d'utilisation |
RU2544856C2 (ru) | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
WO2009111540A1 (fr) | 2008-03-04 | 2009-09-11 | Medivation Neurology, Inc. | Procédés pour préparer des carbolines substituées par pyridyléthyle |
CL2009000724A1 (es) | 2008-03-24 | 2009-05-29 | Medivation Technologies Inc | Compuestos derivados de 1,2,3,4-tetrahidro-pirido[3,4-b]indol, moduladores del receptor de histamina, serotonina y dopamina; composicion farmaceutica; kit farmaceutico; y uso para tratar un trastorno cognitivo, psicotico, mediado por neurotransmisores y/o neurologico. |
JP5597188B2 (ja) | 2008-03-27 | 2014-10-01 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換されたスピロ環状シクロヘキサン誘導体 |
WO2009135091A1 (fr) | 2008-04-30 | 2009-11-05 | Medivation Technologies, Inc. | Utilisation d’asénapine et composés associés pour le traitement de maladies ou de conditions neurales ou non |
US20100029706A1 (en) | 2008-07-30 | 2010-02-04 | Edison Parmaceuticals, Inc. a Delaware Corporation | HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS |
US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
AR073924A1 (es) | 2008-10-31 | 2010-12-09 | Medivation Technologies Inc | Azepino[4, 5-b]indoles, una composicion farmaceutica y kits que los comprenden y su uso en la modulacion de un receptor de histamina. |
EP2346332A4 (fr) | 2008-10-31 | 2012-08-08 | Medivation Technologies Inc | Pyridoý4,3-b¨indoles contenant des fragments rigides |
US8362277B2 (en) | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
US9962368B2 (en) | 2009-01-09 | 2018-05-08 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
US9095572B2 (en) | 2009-01-09 | 2015-08-04 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
US8604074B2 (en) | 2009-01-09 | 2013-12-10 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
CN102480955B (zh) | 2009-04-29 | 2015-08-05 | 梅迪维新技术公司 | 吡啶并[4,3-b]吲哚类和使用方法 |
EP2424366B1 (fr) | 2009-04-29 | 2016-02-17 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles et leurs méthodes d'utilisation |
RU2009128817A (ru) | 2009-07-28 | 2011-02-10 | Общество с ограниченной ответственностью "Инномед" (RU) | Производные гидрированных пиридо[4,3-b]индолов, фармацевтическая композиция, способы получения и применения |
WO2011014695A1 (fr) | 2009-07-29 | 2011-02-03 | Medivation Technologies, Inc. | Nouveaux 2, 3, 4, 5-tétrahydro-1h-pyrido[4,3-b]indoles et leurs procédés d'utilisation |
JP5779183B2 (ja) | 2009-09-23 | 2015-09-16 | メディベイション テクノロジーズ, インコーポレイテッド | ピリド[4,3−b]インドールおよび使用方法 |
WO2011038164A1 (fr) | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Composés hétérocycliques pontés et leurs méthodes d'utilisation |
AU2010298168B2 (en) | 2009-09-23 | 2015-11-19 | Medivation Technologies, Inc. | Pyrido(3,4-b)indoles and methods of use |
EP2480079A4 (fr) | 2009-09-23 | 2015-04-08 | Medivation Technologies Inc | Pyrido(3,4-b)indoles et leurs méthodes d'utilisation |
WO2011103433A1 (fr) | 2010-02-18 | 2011-08-25 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole et dérivés de pyrido[3,4-b]indole et procédés d'utilisation |
US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
US20130172320A1 (en) | 2010-02-18 | 2013-07-04 | Sarvajit Chakravarty | Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
WO2011103430A1 (fr) | 2010-02-19 | 2011-08-25 | Medivation Technologies, Inc. | Dérivés de pyrido[4,3-b]indole et de pyrido[3,4-b]indole et procédés d'utilisation |
WO2011103448A1 (fr) | 2010-02-19 | 2011-08-25 | Medivation Technologies, Inc. | Procédés et compositions pour traiter des troubles psychotiques utilisant une thérapie d'association antipsychotique |
WO2012112963A1 (fr) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Composés et procédés pour le traitement de l'hypertension |
US20140303144A1 (en) | 2011-02-18 | 2014-10-09 | Medivation Technologies, Inc. | Compounds and methods of treating hypertension |
WO2012112964A2 (fr) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Dérivés de pyrido[4,3-b]indole et de pyrido[3,4-b]indole et procédés d'utilisation |
IN2013MN01699A (fr) | 2011-02-18 | 2015-06-12 | Medivation Technologies Inc | |
WO2014031170A1 (fr) | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Dérivés pyrido[4,3-b]indole et pyrido[3,4-b]indole et méthodes d'utilisation |
US20150315188A1 (en) | 2012-08-22 | 2015-11-05 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
EP2925129A4 (fr) | 2012-08-24 | 2016-06-08 | Univ Texas | Composés pro-neurogènes |
US9499519B2 (en) | 2012-12-26 | 2016-11-22 | Medivation Technologies, Inc. | Fused pyrimidine compounds and use thereof |
-
2010
- 2010-09-23 JP JP2012531042A patent/JP5779183B2/ja not_active Expired - Fee Related
- 2010-09-23 WO PCT/US2010/050078 patent/WO2011038161A1/fr active Application Filing
- 2010-09-23 EP EP10819490A patent/EP2480078A4/fr not_active Withdrawn
- 2010-09-23 US US12/889,338 patent/US8859561B2/en not_active Expired - Fee Related
- 2010-09-23 AU AU2010298166A patent/AU2010298166B2/en not_active Ceased
- 2010-09-23 CN CN201080052847.4A patent/CN102711468B/zh not_active Expired - Fee Related
- 2010-09-23 BR BR112012006640A patent/BR112012006640A2/pt not_active IP Right Cessation
- 2010-09-23 CA CA2775328A patent/CA2775328A1/fr not_active Abandoned
-
2013
- 2013-03-08 US US13/791,570 patent/US20130184303A1/en not_active Abandoned
- 2013-03-08 US US13/791,874 patent/US9199996B2/en not_active Expired - Fee Related
- 2013-03-08 US US13/791,871 patent/US9045482B2/en not_active Expired - Fee Related
- 2013-04-02 HK HK13104012.1A patent/HK1176811A1/xx not_active IP Right Cessation
-
2014
- 2014-09-12 US US14/485,238 patent/US9580425B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009120720A1 (fr) * | 2008-03-24 | 2009-10-01 | Medivation Technologies,Inc. | Composés hétérocycliques pontés et leurs procédés d'utilisation |
WO2010036998A2 (fr) * | 2008-09-29 | 2010-04-01 | Abbott Laboratories | Dérivés d’indole et d’indoline et procédés d’utilisation de ceux-ci |
WO2011008312A2 (fr) * | 2009-07-14 | 2011-01-20 | Abbott Laboratories | Dérivés indole et indoline et leurs procédés dutilisation |
Non-Patent Citations (2)
Title |
---|
MEWSHAW RICHARD E ET AL: "Synthesis and in vitro evaluation of 5,6,7,8,9,10-hexahydro-7,10-imin ocyclohept(b)indoles: High-affinity ligands for the N,N'-di-o-tolylguanidine-labeled sigma binding site", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 36, no. 3, 1 January 1993 (1993-01-01), pages 343 - 352, XP002529798, ISSN: 0022-2623, DOI: 10.1021/JM00055A005 * |
See also references of WO2011038161A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2775328A1 (fr) | 2011-03-31 |
BR112012006640A2 (pt) | 2019-09-24 |
US20130184304A1 (en) | 2013-07-18 |
US20150005322A1 (en) | 2015-01-01 |
EP2480078A1 (fr) | 2012-08-01 |
CN102711468B (zh) | 2014-07-09 |
JP2013505945A (ja) | 2013-02-21 |
AU2010298166B2 (en) | 2015-09-17 |
US20110245272A1 (en) | 2011-10-06 |
JP5779183B2 (ja) | 2015-09-16 |
HK1176811A1 (en) | 2013-08-09 |
US8859561B2 (en) | 2014-10-14 |
US9580425B2 (en) | 2017-02-28 |
US20130190344A1 (en) | 2013-07-25 |
US20130184303A1 (en) | 2013-07-18 |
WO2011038161A1 (fr) | 2011-03-31 |
US9199996B2 (en) | 2015-12-01 |
AU2010298166A1 (en) | 2012-04-19 |
CN102711468A (zh) | 2012-10-03 |
US9045482B2 (en) | 2015-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2424366A4 (fr) | Pyrido[4,3-b]indoles et leurs méthodes d'utilisation | |
EP2424364A4 (fr) | Pyrido [4,3-b] indoles et procédés d'utilisation | |
EP2480080A4 (fr) | Pyrido[3,4-b]indoles et leurs méthodes d'utilisation | |
EP2480078A4 (fr) | Pyrido[4,3-b]indoles et leurs méthodes d'utilisation | |
EP2480079A4 (fr) | Pyrido(3,4-b)indoles et leurs méthodes d'utilisation | |
HK1158636A1 (en) | Pyrido [3,4-b] indoles and methods of use [34-b] | |
EP2244708A4 (fr) | Composés inédits de 2,3,4,5-tétrahydro-1h-pyrido [4,3-b] indole et leurs procédés d'utilisation | |
HK1253364B (zh) | 1h-吡唑並[3,4-b]吡啶及其治療應用 | |
IL219424A0 (en) | IMIDAZO [1,2-b] PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS | |
EP2348847A4 (fr) | Azépino [4,5-b] indoles et procédés pour leur utilisation | |
HRP20182078T1 (hr) | Derivati cis-tetrahidro-spiro(cikloheksan-1,1’-pirido[3,4-b]indol)-4-amina | |
EP2145887A4 (fr) | 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indole substitués et procédés de leur fabrication et utilisation | |
IL206330A0 (en) | PYRIDO [2,3-b]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE | |
IL213993A (en) | History of 4,3,2,1-tetrahydropyrido [3,2-b] pyrazine-2-one and pharmaceutical preparations containing them | |
ME01558B (fr) | Activateurs thiéno [2,3-b]pyridinedione de l'ampk et utilisations thérapeutiques de ceux-ci | |
EP2448585A4 (fr) | Antagonistes de mch-1 d azépino[b]indole et pyrido-pyrrolo-azépine azinone-substitué, procédés de préparation, et utilisation de ceux-ci | |
IL222080B (en) | 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives | |
IL215286A0 (en) | 9h-pyrrolo[2,3-b:5,4-c]dipridine azacarboline derivatives, preparation thereof, and therapeutic use thereof | |
IL220448A (en) | Pyridine [3,2 - d] Pyrimidine - 7 (8h) - Their medical uses and uses | |
EP2350212A4 (fr) | Polyamino-acétonitriles, leurs procédés de préparation et leur utilisation | |
PL390846A1 (pl) | Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny | |
HK1150388A1 (en) | New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole compounds and methods of use thereof 2345--1h-[43-b] | |
IL246841A0 (en) | Bicyclic derivatives [2,2,2] and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120330 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130205 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 471/18 20060101ALI20130130BHEP Ipc: A61K 31/40 20060101AFI20130130BHEP Ipc: A61P 25/00 20060101ALI20130130BHEP Ipc: C07D 471/14 20060101ALI20130130BHEP Ipc: C07D 471/04 20060101ALI20130130BHEP Ipc: C07D 471/22 20060101ALI20130130BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1173914 Country of ref document: HK |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MEDIVATION TECHNOLOGIES, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20170401 |